Acceler8 Clinical Research Ltd 13949356 false 2025-04-01 2026-03-31 2026-03-31 The principal activity of the company is that of scientific activities Digita Accounts Production Advanced 6.30.9574.0 true 13949356 2025-04-01 2026-03-31 13949356 2026-03-31 13949356 core:CurrentFinancialInstruments core:WithinOneYear 2026-03-31 13949356 bus:Micro-entities 2025-04-01 2026-03-31 13949356 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 13949356 bus:FilletedAccounts 2025-04-01 2026-03-31 13949356 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 13949356 bus:RegisteredOffice 2025-04-01 2026-03-31 13949356 bus:Director1 2025-04-01 2026-03-31 13949356 bus:Director2 2025-04-01 2026-03-31 13949356 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 13949356 countries:AllCountries 2025-04-01 2026-03-31 13949356 2024-04-01 2025-03-31 13949356 2025-03-31 13949356 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 iso4217:GBP xbrli:pure

Registration number: 13949356

Acceler8 Clinical Research Ltd

Unaudited Filleted Financial Statements

for the Year Ended 31 March 2026

 

Acceler8 Clinical Research Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

Acceler8 Clinical Research Ltd

Company Information

Directors

Mrs Kerri Clare Campbell

Mr Ewan James Campbell

Registered office

Unit 1, Mere View Barn
Park Lane
Pickmere
Knutsford
Cheshire
WA16 0LG

 

Acceler8 Clinical Research Ltd

(Registration number: 13949356)
Balance Sheet as at 31 March 2026

2026
£

2025
£

Fixed assets

102,719

101,670

Current assets

98,779

67,363

Prepayments and accrued income

2,286

3,829

Creditors: Amounts falling due within one year

(10,876)

(48,570)

Net current assets

90,189

22,622

Total assets less current liabilities

192,908

124,292

Accruals and deferred income

(48,234)

(12,210)

 

144,674

112,082

Capital and reserves

144,674

112,082

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
Unit 1, Mere View Barn
Park Lane
Pickmere
Knutsford
Cheshire
WA16 0LG
United Kingdom

These financial statements were authorised for issue by the Board on 30 September 2026.

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2025 - 3).

For the financial year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

•

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

 

Acceler8 Clinical Research Ltd

(Registration number: 13949356)
Balance Sheet as at 31 March 2026

Approved and authorised by the Board on 30 September 2026 and signed on its behalf by:
 

.........................................
Mrs Kerri Clare Campbell
Director

.........................................
Mr Ewan James Campbell
Director